Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.8 | spleen focus forming virus (SFFV) proviral integration oncogene |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_91096772_91098746 | Spi1 | 979 | 0.396683 | 0.68 | 2.0e-09 | Click! |
chr2_91083142_91083406 | Spi1 | 866 | 0.433452 | 0.62 | 1.1e-07 | Click! |
chr2_91098764_91098939 | Spi1 | 2071 | 0.194378 | 0.59 | 9.1e-07 | Click! |
chr2_91081779_91082870 | Spi1 | 66 | 0.949499 | 0.43 | 6.4e-04 | Click! |
chr2_91101701_91101852 | Spi1 | 4996 | 0.122271 | 0.41 | 1.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_64810297_64813272 | 29.42 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr7_45523041_45524800 | 25.70 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr7_44479611_44481283 | 22.63 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4070 |
0.08 |
chrX_170676003_170677019 | 20.64 |
Asmt |
acetylserotonin O-methyltransferase |
3867 |
0.35 |
chr11_97439854_97442222 | 19.93 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr7_101377838_101379825 | 19.89 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr11_103102696_103105788 | 19.51 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr11_75165245_75169157 | 19.14 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr12_32208046_32209200 | 18.13 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr3_137980299_137981827 | 17.96 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr1_51288641_51290950 | 17.63 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr12_108765285_108766682 | 16.89 |
Gm33682 |
predicted gene, 33682 |
3013 |
0.15 |
chr1_91054645_91055420 | 16.25 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
1446 |
0.43 |
chr2_9882196_9886301 | 16.12 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr11_102217551_102219283 | 16.01 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr4_154024404_154026596 | 15.74 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr2_103958009_103958847 | 15.67 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr10_5287995_5289689 | 15.62 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr6_87429843_87431054 | 15.62 |
Bmp10 |
bone morphogenetic protein 10 |
1454 |
0.34 |
chr14_75178051_75179727 | 15.60 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr15_5107710_5108629 | 15.45 |
Card6 |
caspase recruitment domain family, member 6 |
315 |
0.81 |
chr5_102724663_102726037 | 15.32 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr3_14889110_14890285 | 15.18 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr19_7018033_7019009 | 15.15 |
Fermt3 |
fermitin family member 3 |
824 |
0.38 |
chr15_103253562_103255772 | 15.11 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr2_18821363_18822378 | 14.94 |
Carlr |
cardiac and apoptosis-related long non-coding RNA |
20052 |
0.17 |
chr10_7472799_7473709 | 14.80 |
Ulbp1 |
UL16 binding protein 1 |
87 |
0.97 |
chr4_43559728_43560658 | 14.80 |
Tln1 |
talin 1 |
1733 |
0.15 |
chr2_25195300_25197035 | 14.70 |
Tor4a |
torsin family 4, member A |
592 |
0.43 |
chr8_122546551_122549259 | 14.67 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr2_36230119_36231737 | 14.64 |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
372 |
0.79 |
chr7_127992791_127993997 | 14.63 |
Gm45205 |
predicted gene 45205 |
125 |
0.49 |
chr19_17355077_17356896 | 14.60 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
681 |
0.75 |
chr6_31125380_31126701 | 14.56 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr17_48300015_48301474 | 14.56 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr2_105125289_105128976 | 14.33 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr5_114969022_114970855 | 14.23 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr19_5660333_5662014 | 14.23 |
Sipa1 |
signal-induced proliferation associated gene 1 |
462 |
0.59 |
chr9_111055888_111057545 | 14.22 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr3_79885722_79887545 | 14.22 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr5_117133717_117134877 | 13.98 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr12_111943340_111944555 | 13.88 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
199 |
0.89 |
chr5_147304305_147307985 | 13.81 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr11_97511052_97512791 | 13.65 |
Gm11611 |
predicted gene 11611 |
9974 |
0.12 |
chr16_36934847_36935880 | 13.58 |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
380 |
0.77 |
chr7_45238275_45239242 | 13.54 |
Cd37 |
CD37 antigen |
38 |
0.92 |
chr11_5897192_5898699 | 13.34 |
Myl7 |
myosin, light polypeptide 7, regulatory |
837 |
0.46 |
chr14_27237814_27239092 | 13.33 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr11_87756102_87757558 | 13.32 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr4_46040988_46042013 | 13.16 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr3_138130180_138131364 | 13.15 |
Mttp |
microsomal triglyceride transfer protein |
605 |
0.65 |
chr19_34253411_34255499 | 13.11 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr11_86586191_86587628 | 13.05 |
Vmp1 |
vacuole membrane protein 1 |
28 |
0.97 |
chr10_80347716_80349512 | 13.00 |
Adamtsl5 |
ADAMTS-like 5 |
202 |
0.82 |
chr11_117779316_117780928 | 13.00 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr15_101411658_101413570 | 12.95 |
Krt7 |
keratin 7 |
165 |
0.64 |
chr13_49306917_49307703 | 12.83 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
1930 |
0.34 |
chr9_107982030_107984233 | 12.81 |
Gm20661 |
predicted gene 20661 |
38 |
0.54 |
chr14_63268302_63270010 | 12.70 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr15_41751298_41752572 | 12.41 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr1_87620304_87621692 | 12.36 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr14_77904388_77905097 | 12.28 |
Epsti1 |
epithelial stromal interaction 1 (breast) |
335 |
0.9 |
chr8_88300415_88300996 | 12.27 |
Adcy7 |
adenylate cyclase 7 |
326 |
0.89 |
chr9_107975554_107976970 | 12.23 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr7_24373502_24374343 | 12.22 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
3584 |
0.11 |
chr14_60732734_60734396 | 12.02 |
Spata13 |
spermatogenesis associated 13 |
659 |
0.72 |
chr8_25542987_25545804 | 11.98 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr5_119672433_119673011 | 11.95 |
Tbx3os1 |
T-box 3, opposite strand 1 |
1357 |
0.31 |
chr6_136854322_136855143 | 11.95 |
Art4 |
ADP-ribosyltransferase 4 |
3001 |
0.12 |
chr4_154926952_154928851 | 11.88 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr7_44350602_44354420 | 11.85 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr17_44134755_44136009 | 11.83 |
Clic5 |
chloride intracellular channel 5 |
614 |
0.77 |
chr3_89436767_89437632 | 11.73 |
Pbxip1 |
pre B cell leukemia transcription factor interacting protein 1 |
443 |
0.64 |
chr1_136945385_136947968 | 11.68 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr1_125676834_125678312 | 11.47 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr2_91949326_91950727 | 11.45 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr12_117657998_117660727 | 11.45 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr7_100492685_100494805 | 11.40 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr14_66279066_66281333 | 11.37 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr5_90492212_90493160 | 11.37 |
Afp |
alpha fetoprotein |
1448 |
0.33 |
chr10_97566192_97567945 | 11.37 |
Lum |
lumican |
1940 |
0.32 |
chr1_161766766_161767491 | 11.36 |
Gm5049 |
predicted gene 5049 |
21072 |
0.12 |
chr19_7294483_7295524 | 11.32 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr7_81057643_81058977 | 11.31 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr16_58672078_58672766 | 11.26 |
Cpox |
coproporphyrinogen oxidase |
1714 |
0.26 |
chr8_117701899_117703135 | 11.21 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
430 |
0.77 |
chr3_89136417_89137539 | 11.19 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr6_30172641_30174725 | 11.17 |
Rncr4 |
retina expressed non-coding RNA 4 |
790 |
0.51 |
chr2_84475523_84476677 | 11.01 |
Tfpi |
tissue factor pathway inhibitor |
648 |
0.7 |
chrX_143825863_143827628 | 11.00 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr8_84701273_84703379 | 10.97 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr13_32965217_32966457 | 10.85 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
334 |
0.84 |
chr14_75136350_75137361 | 10.84 |
Gm15628 |
predicted gene 15628 |
57 |
0.84 |
chr11_78984345_78985263 | 10.75 |
Lgals9 |
lectin, galactose binding, soluble 9 |
27 |
0.98 |
chr14_54227309_54228123 | 10.74 |
Traj1 |
T cell receptor alpha joining 1 |
8902 |
0.08 |
chr18_35739288_35740804 | 10.72 |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
30 |
0.95 |
chr6_48676062_48676718 | 10.63 |
Gimap9 |
GTPase, IMAP family member 9 |
261 |
0.79 |
chr10_7831857_7832952 | 10.56 |
Zc3h12d |
zinc finger CCCH type containing 12D |
66 |
0.95 |
chr2_118728020_118728693 | 10.47 |
Plcb2 |
phospholipase C, beta 2 |
3 |
0.96 |
chr7_127296174_127297414 | 10.43 |
Itgal |
integrin alpha L |
384 |
0.68 |
chr7_19082814_19086200 | 10.40 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr5_72796212_72796844 | 10.34 |
Tec |
tec protein tyrosine kinase |
10508 |
0.15 |
chr14_52140471_52142121 | 10.32 |
Rpgrip1 |
retinitis pigmentosa GTPase regulator interacting protein 1 |
4068 |
0.13 |
chr11_98448535_98449780 | 10.29 |
Grb7 |
growth factor receptor bound protein 7 |
2089 |
0.15 |
chr10_59403301_59404650 | 10.23 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr8_121082801_121085531 | 10.19 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr17_47174837_47175202 | 10.17 |
Trerf1 |
transcriptional regulating factor 1 |
33803 |
0.17 |
chr7_97453001_97454277 | 10.14 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
417 |
0.79 |
chr11_83850990_83852424 | 10.13 |
Hnf1b |
HNF1 homeobox B |
535 |
0.69 |
chr8_57320946_57324000 | 10.11 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr15_102150305_102151233 | 10.10 |
Soat2 |
sterol O-acyltransferase 2 |
243 |
0.86 |
chr2_35334268_35334953 | 10.05 |
Stom |
stomatin |
2366 |
0.21 |
chr7_31040855_31042728 | 10.03 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr8_68119212_68120289 | 10.01 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
1563 |
0.51 |
chr1_4491637_4493723 | 9.97 |
Sox17 |
SRY (sex determining region Y)-box 17 |
924 |
0.48 |
chr15_84324521_84325304 | 9.96 |
Parvg |
parvin, gamma |
117 |
0.94 |
chr11_83849571_83850989 | 9.95 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr17_85686512_85689764 | 9.94 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr2_167588684_167589456 | 9.93 |
Gm11475 |
predicted gene 11475 |
2325 |
0.19 |
chr8_68205432_68207408 | 9.93 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
363 |
0.91 |
chr7_100854551_100855928 | 9.93 |
Relt |
RELT tumor necrosis factor receptor |
190 |
0.92 |
chr11_95833615_95836077 | 9.91 |
Abi3 |
ABI gene family, member 3 |
1044 |
0.33 |
chr11_95841518_95842457 | 9.81 |
Abi3 |
ABI gene family, member 3 |
111 |
0.73 |
chr10_39612918_39613668 | 9.80 |
Traf3ip2 |
TRAF3 interacting protein 2 |
359 |
0.48 |
chrX_73909796_73911465 | 9.74 |
Arhgap4 |
Rho GTPase activating protein 4 |
599 |
0.57 |
chr2_24386288_24387076 | 9.71 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
65 |
0.97 |
chr4_63402318_63403749 | 9.70 |
Akna |
AT-hook transcription factor |
321 |
0.84 |
chr2_57997628_57998772 | 9.69 |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
316 |
0.9 |
chr8_23035959_23037041 | 9.68 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr11_48869797_48870455 | 9.68 |
Irgm1 |
immunity-related GTPase family M member 1 |
1248 |
0.29 |
chr9_105520039_105521535 | 9.68 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr4_136177602_136178758 | 9.65 |
E2f2 |
E2F transcription factor 2 |
2603 |
0.21 |
chr3_95673620_95674691 | 9.61 |
Adamtsl4 |
ADAMTS-like 4 |
2996 |
0.14 |
chr18_32557788_32558922 | 9.55 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr3_27316895_27317871 | 9.54 |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
322 |
0.89 |
chr3_135608020_135608578 | 9.52 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
29 |
0.98 |
chr3_52029454_52030701 | 9.46 |
Gm37465 |
predicted gene, 37465 |
26052 |
0.1 |
chr15_78926966_78928482 | 9.42 |
Lgals1 |
lectin, galactose binding, soluble 1 |
998 |
0.29 |
chr9_22131114_22132438 | 9.36 |
Acp5 |
acid phosphatase 5, tartrate resistant |
39 |
0.93 |
chr7_3292731_3293965 | 9.35 |
Myadm |
myeloid-associated differentiation marker |
254 |
0.81 |
chr13_20184697_20185309 | 9.34 |
Elmo1 |
engulfment and cell motility 1 |
204 |
0.97 |
chr6_146222065_146222293 | 9.32 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
5364 |
0.27 |
chr15_102460089_102460942 | 9.32 |
Prr13 |
proline rich 13 |
432 |
0.68 |
chr13_106835269_106836682 | 9.27 |
Lrrc70 |
leucine rich repeat containing 70 |
173 |
0.7 |
chr5_32745567_32746421 | 9.26 |
Pisd |
phosphatidylserine decarboxylase |
318 |
0.82 |
chr1_20616777_20618199 | 9.21 |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
552 |
0.78 |
chr2_51981581_51982729 | 9.20 |
Nmi |
N-myc (and STAT) interactor |
8661 |
0.19 |
chr18_61952844_61953759 | 9.18 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
217 |
0.94 |
chr13_100600285_100601357 | 9.17 |
Gm24261 |
predicted gene, 24261 |
3538 |
0.14 |
chr16_44778591_44779189 | 9.16 |
Cd200r1 |
CD200 receptor 1 |
13064 |
0.13 |
chr10_81140191_81141251 | 9.13 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
2768 |
0.1 |
chr4_134869303_134870057 | 9.13 |
Rhd |
Rh blood group, D antigen |
5144 |
0.18 |
chr2_168049043_168050088 | 9.09 |
Gm24327 |
predicted gene, 24327 |
15332 |
0.13 |
chr7_103812275_103812465 | 9.08 |
Hbb-bt |
hemoglobin, beta adult t chain |
1626 |
0.15 |
chr18_11049995_11051717 | 9.06 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr10_8944239_8945864 | 9.06 |
Gm48728 |
predicted gene, 48728 |
6898 |
0.2 |
chr5_119669544_119672401 | 9.05 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr11_60934916_60936338 | 9.05 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3561 |
0.16 |
chr19_10015065_10016667 | 9.04 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr10_60346425_60348008 | 9.03 |
Vsir |
V-set immunoregulatory receptor |
204 |
0.94 |
chr12_87157600_87158466 | 9.03 |
Gstz1 |
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
425 |
0.71 |
chr19_53194082_53195694 | 9.01 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr12_77059916_77060880 | 9.00 |
Gm35189 |
predicted gene, 35189 |
18197 |
0.2 |
chr6_97457802_97459465 | 9.00 |
Frmd4b |
FERM domain containing 4B |
653 |
0.74 |
chr18_62178475_62179981 | 9.00 |
Adrb2 |
adrenergic receptor, beta 2 |
731 |
0.49 |
chr11_77783639_77784980 | 8.99 |
Gm10277 |
predicted gene 10277 |
3438 |
0.18 |
chr2_84936571_84938205 | 8.99 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr10_115817324_115818606 | 8.98 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr2_84634714_84636973 | 8.98 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
2262 |
0.17 |
chr11_4236775_4237615 | 8.94 |
Osm |
oncostatin M |
775 |
0.46 |
chr2_91964507_91965860 | 8.93 |
Dgkz |
diacylglycerol kinase zeta |
404 |
0.78 |
chr9_69454872_69455904 | 8.93 |
Anxa2 |
annexin A2 |
1322 |
0.26 |
chr6_55338294_55340060 | 8.91 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr8_23037877_23038537 | 8.91 |
Ank1 |
ankyrin 1, erythroid |
2976 |
0.25 |
chr10_127749619_127751660 | 8.91 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr6_141250969_141251472 | 8.89 |
Gm28523 |
predicted gene 28523 |
1211 |
0.38 |
chr5_139793033_139793518 | 8.89 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
1741 |
0.24 |
chr11_5505783_5506171 | 8.88 |
Gm11963 |
predicted gene 11963 |
7137 |
0.14 |
chr5_30913519_30915234 | 8.85 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr18_75384437_75388058 | 8.84 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr1_171439042_171439737 | 8.83 |
F11r |
F11 receptor |
1810 |
0.19 |
chr15_97361270_97362062 | 8.82 |
Pced1b |
PC-esterase domain containing 1B |
449 |
0.88 |
chr10_22817553_22818325 | 8.81 |
Gm10824 |
predicted gene 10824 |
2190 |
0.24 |
chr7_133114831_133116529 | 8.79 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr10_121692942_121693624 | 8.78 |
Gm35865 |
predicted gene, 35865 |
11752 |
0.17 |
chr8_88635072_88636330 | 8.77 |
Snx20 |
sorting nexin 20 |
400 |
0.84 |
chr19_4301696_4304008 | 8.76 |
Grk2 |
G protein-coupled receptor kinase 2 |
2356 |
0.14 |
chr3_127123282_127124895 | 8.75 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr10_34483356_34484742 | 8.74 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr3_65953043_65954518 | 8.72 |
Ccnl1 |
cyclin L1 |
787 |
0.49 |
chr6_52202371_52204739 | 8.72 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr4_66827390_66828201 | 8.71 |
Tlr4 |
toll-like receptor 4 |
176 |
0.97 |
chr14_55787894_55789141 | 8.69 |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
125 |
0.9 |
chr2_121036316_121036674 | 8.67 |
Epb42 |
erythrocyte membrane protein band 4.2 |
186 |
0.9 |
chr4_87805839_87806716 | 8.67 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
17 |
0.99 |
chr4_152096248_152097724 | 8.66 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
267 |
0.86 |
chr7_19796098_19797425 | 8.62 |
Cblc |
Casitas B-lineage lymphoma c |
32 |
0.93 |
chr4_150001060_150001849 | 8.62 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
164 |
0.94 |
chr6_48738819_48739492 | 8.58 |
Gimap1 |
GTPase, IMAP family member 1 |
48 |
0.54 |
chr10_77112255_77113959 | 8.58 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
11.0 | 44.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
10.5 | 31.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
9.5 | 28.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
9.5 | 37.9 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
9.3 | 28.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
9.3 | 9.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
7.8 | 23.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
7.8 | 23.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
7.3 | 21.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
6.6 | 19.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
6.3 | 25.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.2 | 12.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.2 | 18.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
6.1 | 24.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
5.9 | 17.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
5.6 | 11.1 | GO:0048793 | pronephros development(GO:0048793) |
5.6 | 16.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
5.5 | 11.1 | GO:0060435 | bronchiole development(GO:0060435) |
5.3 | 16.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.3 | 21.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
5.2 | 26.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
5.1 | 25.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
5.1 | 15.2 | GO:0061010 | gall bladder development(GO:0061010) |
5.0 | 15.1 | GO:0003166 | bundle of His development(GO:0003166) |
5.0 | 20.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
4.9 | 19.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
4.8 | 9.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
4.8 | 14.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
4.8 | 14.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.8 | 14.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.8 | 14.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
4.7 | 14.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.7 | 14.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
4.6 | 18.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
4.6 | 13.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
4.6 | 13.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
4.6 | 4.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
4.6 | 13.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
4.5 | 9.0 | GO:0002432 | granuloma formation(GO:0002432) |
4.5 | 17.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.4 | 17.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.4 | 17.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
4.4 | 22.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
4.4 | 13.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
4.4 | 26.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.4 | 13.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
4.4 | 8.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
4.3 | 17.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.3 | 4.3 | GO:0070627 | ferrous iron import(GO:0070627) |
4.3 | 12.9 | GO:0070836 | caveola assembly(GO:0070836) |
4.2 | 12.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.2 | 16.9 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
4.2 | 25.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
4.2 | 16.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.2 | 12.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
4.1 | 8.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
4.1 | 16.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
4.0 | 8.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
4.0 | 19.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
4.0 | 12.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.0 | 19.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
4.0 | 19.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
3.9 | 11.8 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
3.9 | 19.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
3.9 | 11.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
3.9 | 11.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.9 | 7.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.8 | 11.5 | GO:0036394 | amylase secretion(GO:0036394) |
3.8 | 18.9 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
3.8 | 11.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
3.8 | 7.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
3.8 | 11.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
3.7 | 11.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
3.7 | 7.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.7 | 11.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
3.7 | 3.7 | GO:2001225 | regulation of chloride transport(GO:2001225) |
3.6 | 7.3 | GO:0070295 | renal water absorption(GO:0070295) |
3.6 | 3.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
3.6 | 14.5 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
3.6 | 21.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
3.6 | 21.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.6 | 14.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.6 | 17.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.5 | 3.5 | GO:0007494 | midgut development(GO:0007494) |
3.5 | 3.5 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
3.5 | 7.0 | GO:0072277 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
3.5 | 10.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.5 | 10.5 | GO:0008228 | opsonization(GO:0008228) |
3.4 | 10.3 | GO:0035483 | gastric emptying(GO:0035483) |
3.4 | 3.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
3.4 | 10.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
3.4 | 10.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
3.4 | 10.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.3 | 10.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.3 | 10.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.3 | 10.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.3 | 9.9 | GO:0007525 | somatic muscle development(GO:0007525) |
3.3 | 9.8 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
3.2 | 6.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.2 | 9.5 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
3.1 | 15.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
3.1 | 9.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
3.1 | 21.7 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
3.1 | 9.3 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.1 | 12.3 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.1 | 6.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.1 | 9.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
3.1 | 15.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.0 | 9.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.0 | 12.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
3.0 | 18.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
3.0 | 60.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
3.0 | 9.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.0 | 21.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.0 | 12.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.0 | 6.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.0 | 3.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
3.0 | 11.8 | GO:0097286 | iron ion import(GO:0097286) |
3.0 | 8.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.9 | 5.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.9 | 17.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
2.9 | 11.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.9 | 8.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
2.9 | 20.2 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
2.9 | 5.8 | GO:0050904 | diapedesis(GO:0050904) |
2.9 | 8.7 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
2.9 | 14.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
2.9 | 2.9 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
2.9 | 8.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
2.9 | 2.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.9 | 11.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.8 | 17.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.8 | 31.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
2.8 | 8.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.8 | 11.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.8 | 11.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.8 | 2.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
2.8 | 2.8 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
2.8 | 8.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.7 | 2.7 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.7 | 8.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.7 | 16.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.7 | 5.4 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
2.7 | 27.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.7 | 8.1 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
2.7 | 13.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.7 | 8.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.7 | 8.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
2.7 | 2.7 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
2.7 | 2.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.6 | 23.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.6 | 2.6 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
2.6 | 28.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
2.6 | 15.6 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.6 | 20.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
2.6 | 18.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.6 | 5.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.6 | 7.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
2.6 | 5.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.6 | 10.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.6 | 7.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.6 | 2.6 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
2.5 | 2.5 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
2.5 | 5.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.5 | 5.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.5 | 5.0 | GO:0003163 | sinoatrial node development(GO:0003163) |
2.5 | 22.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.5 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.5 | 9.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
2.5 | 17.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.5 | 4.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.4 | 24.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.4 | 14.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
2.4 | 7.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.4 | 7.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.4 | 7.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.4 | 11.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.4 | 2.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
2.3 | 4.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
2.3 | 7.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.3 | 2.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.3 | 2.3 | GO:0044351 | macropinocytosis(GO:0044351) |
2.3 | 2.3 | GO:0002159 | desmosome assembly(GO:0002159) |
2.3 | 6.9 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
2.3 | 4.6 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
2.3 | 4.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.3 | 4.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.3 | 4.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.3 | 6.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.3 | 13.6 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
2.3 | 6.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.3 | 4.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.3 | 6.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.3 | 6.8 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.2 | 4.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.2 | 4.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
2.2 | 4.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.2 | 4.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.2 | 6.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
2.2 | 8.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.2 | 2.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.2 | 4.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.1 | 6.4 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
2.1 | 10.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.1 | 6.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
2.1 | 10.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
2.1 | 8.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
2.1 | 16.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.1 | 4.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.1 | 10.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
2.1 | 10.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
2.1 | 2.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.1 | 2.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.1 | 6.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
2.0 | 16.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
2.0 | 22.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
2.0 | 2.0 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
2.0 | 20.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.0 | 8.1 | GO:0018214 | protein carboxylation(GO:0018214) |
2.0 | 6.0 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.0 | 2.0 | GO:0035564 | regulation of kidney size(GO:0035564) |
2.0 | 2.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.0 | 8.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.0 | 6.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.0 | 14.0 | GO:0015825 | L-serine transport(GO:0015825) |
2.0 | 6.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
2.0 | 15.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.0 | 5.9 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
2.0 | 5.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.0 | 15.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.0 | 2.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.0 | 5.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.0 | 13.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.0 | 7.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.0 | 3.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.0 | 2.0 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
2.0 | 2.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.0 | 31.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.0 | 5.9 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.9 | 5.8 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.9 | 1.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.9 | 7.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.9 | 1.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.9 | 5.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.9 | 5.8 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.9 | 5.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.9 | 24.9 | GO:0048821 | erythrocyte development(GO:0048821) |
1.9 | 11.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
1.9 | 1.9 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
1.9 | 13.3 | GO:0032782 | bile acid secretion(GO:0032782) |
1.9 | 7.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.9 | 3.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.9 | 13.2 | GO:0060613 | fat pad development(GO:0060613) |
1.9 | 7.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.9 | 1.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.9 | 11.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.9 | 5.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.8 | 5.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.8 | 1.8 | GO:0061196 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
1.8 | 5.5 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.8 | 3.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.8 | 5.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.8 | 7.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.8 | 1.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.8 | 5.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.8 | 14.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.8 | 5.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
1.8 | 16.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
1.8 | 9.1 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
1.8 | 5.4 | GO:0018343 | protein farnesylation(GO:0018343) |
1.8 | 10.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.8 | 1.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.8 | 3.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.8 | 7.2 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.8 | 1.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.8 | 3.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
1.8 | 14.2 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.8 | 17.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.8 | 3.5 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.8 | 3.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.8 | 3.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.8 | 8.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.8 | 7.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.8 | 1.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.8 | 15.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.8 | 1.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.8 | 1.8 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.7 | 5.2 | GO:0007418 | ventral midline development(GO:0007418) |
1.7 | 7.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.7 | 7.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.7 | 15.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.7 | 3.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.7 | 1.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.7 | 5.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.7 | 1.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.7 | 3.4 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.7 | 5.1 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.7 | 27.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.7 | 8.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.7 | 3.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.7 | 3.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.7 | 15.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.7 | 20.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.7 | 1.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.7 | 3.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.7 | 5.0 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
1.7 | 3.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
1.7 | 5.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.7 | 5.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.7 | 5.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.7 | 9.9 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
1.7 | 5.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.7 | 5.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.7 | 5.0 | GO:0000087 | mitotic M phase(GO:0000087) |
1.7 | 5.0 | GO:0097531 | mast cell migration(GO:0097531) |
1.6 | 4.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.6 | 6.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
1.6 | 6.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.6 | 6.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.6 | 3.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.6 | 3.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.6 | 4.9 | GO:0006562 | proline catabolic process(GO:0006562) |
1.6 | 3.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.6 | 1.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.6 | 16.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.6 | 4.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.6 | 11.4 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
1.6 | 9.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.6 | 1.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.6 | 3.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.6 | 16.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.6 | 4.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.6 | 1.6 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
1.6 | 3.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.6 | 8.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.6 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.6 | 6.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.6 | 14.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.6 | 4.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.6 | 9.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.6 | 9.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.6 | 28.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.6 | 9.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.6 | 1.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.6 | 3.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
1.6 | 6.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.6 | 7.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.6 | 10.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.6 | 4.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.6 | 4.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.5 | 4.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.5 | 13.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.5 | 3.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.5 | 10.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.5 | 7.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 6.1 | GO:0018158 | protein oxidation(GO:0018158) |
1.5 | 4.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.5 | 4.6 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.5 | 6.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.5 | 3.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.5 | 1.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.5 | 4.5 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
1.5 | 9.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.5 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
1.5 | 1.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.5 | 6.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.5 | 6.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.5 | 4.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.5 | 17.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.5 | 19.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.5 | 5.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.5 | 3.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.5 | 4.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.5 | 1.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.5 | 4.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.5 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 2.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.5 | 13.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.5 | 5.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.5 | 4.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.5 | 1.5 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.4 | 7.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.4 | 1.4 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.4 | 2.9 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
1.4 | 7.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.4 | 7.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.4 | 5.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.4 | 11.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.4 | 4.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.4 | 2.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.4 | 2.9 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.4 | 5.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.4 | 4.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.4 | 1.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.4 | 9.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.4 | 2.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.4 | 2.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.4 | 4.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.4 | 8.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.4 | 5.6 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
1.4 | 7.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.4 | 5.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.4 | 2.8 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
1.4 | 2.8 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.4 | 1.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.4 | 5.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.4 | 1.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.4 | 6.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.4 | 5.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.4 | 1.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.4 | 5.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.4 | 5.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 2.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.4 | 2.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
1.4 | 4.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.4 | 4.1 | GO:0061511 | centriole elongation(GO:0061511) |
1.4 | 5.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.4 | 8.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.4 | 1.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.4 | 1.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.4 | 1.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.4 | 2.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.4 | 2.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.4 | 2.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 4.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.4 | 5.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.4 | 15.0 | GO:0010226 | response to lithium ion(GO:0010226) |
1.4 | 2.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.4 | 1.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.4 | 2.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.3 | 4.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.3 | 17.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.3 | 2.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.3 | 16.1 | GO:0048535 | lymph node development(GO:0048535) |
1.3 | 24.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.3 | 12.0 | GO:0070269 | pyroptosis(GO:0070269) |
1.3 | 9.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.3 | 5.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
1.3 | 6.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.3 | 20.0 | GO:0034340 | response to type I interferon(GO:0034340) |
1.3 | 2.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.3 | 10.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.3 | 16.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.3 | 5.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.3 | 14.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.3 | 10.5 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 6.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.3 | 3.9 | GO:0003096 | renal sodium ion transport(GO:0003096) |
1.3 | 5.3 | GO:0060281 | regulation of oocyte development(GO:0060281) |
1.3 | 15.8 | GO:0072678 | T cell migration(GO:0072678) |
1.3 | 1.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.3 | 5.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.3 | 1.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.3 | 3.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.3 | 2.6 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
1.3 | 9.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.3 | 9.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.3 | 6.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.3 | 6.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.3 | 3.9 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
1.3 | 6.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
1.3 | 5.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.3 | 14.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.3 | 1.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.3 | 3.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.3 | 2.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.3 | 1.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.3 | 2.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.3 | 3.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.3 | 1.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.3 | 6.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.3 | 11.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.3 | 6.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.2 | 13.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.2 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.2 | 8.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.2 | 1.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.2 | 5.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.2 | 5.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.2 | 3.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.2 | 5.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.2 | 7.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.2 | 2.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.2 | 1.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.2 | 14.7 | GO:0051601 | exocyst localization(GO:0051601) |
1.2 | 2.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.2 | 2.5 | GO:0048143 | astrocyte activation(GO:0048143) |
1.2 | 7.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.2 | 1.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.2 | 2.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 3.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.2 | 1.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.2 | 6.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.2 | 27.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.2 | 1.2 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
1.2 | 2.4 | GO:0031033 | myosin filament organization(GO:0031033) |
1.2 | 3.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.2 | 3.6 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 4.8 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.2 | 9.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.2 | 4.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.2 | 1.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.2 | 3.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
1.2 | 11.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.2 | 5.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.2 | 3.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.2 | 42.1 | GO:0045576 | mast cell activation(GO:0045576) |
1.2 | 2.3 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 2.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.2 | 9.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.2 | 1.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.2 | 7.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.2 | 19.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.2 | 4.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.2 | 3.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.2 | 1.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
1.2 | 3.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
1.1 | 2.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
1.1 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.1 | 4.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 2.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.1 | 2.3 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.1 | 5.7 | GO:1904970 | brush border assembly(GO:1904970) |
1.1 | 2.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.1 | 6.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 2.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.1 | 2.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.1 | 2.3 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.1 | 3.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.1 | 3.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
1.1 | 14.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.1 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.1 | 9.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.1 | 3.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.1 | 1.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.1 | 27.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.1 | 1.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.1 | 3.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 3.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 5.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.1 | 3.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.1 | 13.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.1 | 12.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.1 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.1 | 6.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.1 | 6.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.1 | 17.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.1 | 13.0 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.1 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.1 | 6.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.1 | 3.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.1 | 2.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 2.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.1 | 1.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
1.1 | 18.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.1 | 6.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 7.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.1 | 2.1 | GO:0006907 | pinocytosis(GO:0006907) |
1.1 | 5.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.1 | 3.2 | GO:0032439 | endosome localization(GO:0032439) |
1.1 | 12.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.1 | 4.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.0 | 10.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 7.3 | GO:0015858 | nucleoside transport(GO:0015858) |
1.0 | 2.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.0 | 1.0 | GO:0072537 | fibroblast activation(GO:0072537) |
1.0 | 5.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.0 | 3.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
1.0 | 5.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.0 | 1.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.0 | 4.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.0 | 5.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.0 | 4.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.0 | 3.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 3.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.0 | 2.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
1.0 | 1.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.0 | 3.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
1.0 | 1.0 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
1.0 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.0 | 2.1 | GO:0032252 | secretory granule localization(GO:0032252) |
1.0 | 4.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.0 | 1.0 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.0 | 2.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.0 | 10.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.0 | 2.0 | GO:0070166 | enamel mineralization(GO:0070166) |
1.0 | 2.0 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.0 | 4.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.0 | 6.1 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.0 | 3.0 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 8.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.0 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.0 | 2.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.0 | 4.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.0 | 2.0 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.0 | 8.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.0 | 2.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.0 | 4.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.0 | 6.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.0 | 9.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
1.0 | 4.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.0 | 3.0 | GO:0051693 | actin filament capping(GO:0051693) |
1.0 | 6.9 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.0 | 4.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.0 | 1.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 8.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.0 | 4.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.0 | 2.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 1.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.0 | 4.9 | GO:0018101 | protein citrullination(GO:0018101) |
1.0 | 1.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.0 | 3.9 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 2.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.0 | 5.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.0 | 1.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.0 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.0 | 12.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.0 | 1.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
1.0 | 1.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.0 | 2.9 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
1.0 | 12.5 | GO:0030239 | myofibril assembly(GO:0030239) |
1.0 | 1.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.0 | 2.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.0 | 4.8 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
1.0 | 1.0 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.0 | 1.9 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.9 | 3.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.9 | 4.7 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.9 | 4.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 6.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.9 | 4.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.9 | 2.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.9 | 1.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.9 | 1.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.9 | 9.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.9 | 3.7 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.9 | 1.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 2.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.9 | 3.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 11.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.9 | 9.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 14.7 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 2.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.9 | 8.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.9 | 4.6 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.9 | 2.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.9 | 8.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.9 | 4.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.9 | 3.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 0.9 | GO:0032329 | serine transport(GO:0032329) |
0.9 | 4.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.9 | 2.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.9 | 4.5 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.9 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 2.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 16.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.9 | 21.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.9 | 0.9 | GO:0031649 | heat generation(GO:0031649) |
0.9 | 1.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.9 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.9 | 2.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.9 | 0.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.9 | 4.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 2.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 8.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.9 | 5.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.9 | 2.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 2.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 1.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.9 | 4.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.9 | 1.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.9 | 8.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.9 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.9 | 5.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 25.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.9 | 2.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.9 | 2.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.9 | 0.9 | GO:0010159 | specification of organ position(GO:0010159) |
0.9 | 1.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.9 | 17.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.9 | 1.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.9 | 3.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.9 | 1.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.9 | 2.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.9 | 19.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.9 | 1.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.9 | 12.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.9 | 0.9 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.9 | 2.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.9 | 3.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.9 | 0.9 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.9 | 0.9 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 3.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.8 | 1.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.8 | 5.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.8 | 13.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.8 | 3.4 | GO:0018904 | ether metabolic process(GO:0018904) |
0.8 | 0.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.8 | 1.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 0.8 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.8 | 5.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 3.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.8 | 1.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.8 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 3.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.8 | 14.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.8 | 4.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.8 | 4.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.8 | 4.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.8 | 10.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.8 | 1.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.8 | 3.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.8 | 1.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.8 | 4.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 4.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.8 | 0.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.8 | 8.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 4.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 8.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.8 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.8 | 31.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.8 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 1.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.8 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 1.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.8 | 2.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.8 | 1.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.8 | 5.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 4.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.8 | 1.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.8 | 1.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.8 | 1.6 | GO:0060416 | response to growth hormone(GO:0060416) |
0.8 | 2.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 5.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.8 | 2.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.8 | 3.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 2.3 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.8 | 1.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.8 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 3.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 3.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.8 | 4.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.8 | 12.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 0.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.8 | 27.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.8 | 2.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.8 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.8 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 36.3 | GO:0007599 | hemostasis(GO:0007599) |
0.8 | 2.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.8 | 3.0 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.8 | 3.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.8 | 12.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.8 | 1.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 1.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.7 | 5.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.7 | 2.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.7 | 0.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.7 | 4.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.7 | 3.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.7 | 3.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.7 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.7 | 3.7 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.7 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.7 | 0.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 1.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.7 | 2.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 0.7 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.7 | 13.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.7 | 8.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.7 | 1.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 2.2 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.7 | 4.3 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.7 | 1.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.7 | 2.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 0.7 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.7 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.7 | 2.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 0.7 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.7 | 8.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.7 | 0.7 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.7 | 3.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.7 | 2.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.7 | 2.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.7 | 1.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 10.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.7 | 2.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 6.3 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.7 | 2.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.7 | 2.8 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.7 | 0.7 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.7 | 0.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.7 | 3.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.7 | 2.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 3.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 3.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.7 | 0.7 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.7 | 0.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.7 | 4.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.7 | 2.7 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.7 | 0.7 | GO:0071634 | regulation of transforming growth factor beta production(GO:0071634) |
0.7 | 1.4 | GO:0060618 | nipple development(GO:0060618) |
0.7 | 1.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.7 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.7 | 1.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) |
0.7 | 0.7 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.7 | 6.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 10.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.7 | 0.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.7 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 2.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 4.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 2.0 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.7 | 2.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.7 | 5.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.7 | 2.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.7 | 1.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.7 | 1.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 2.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.7 | 2.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.7 | 1.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.7 | 1.3 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.6 | 12.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 0.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 1.9 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.6 | 1.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.6 | 1.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.6 | 1.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.6 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 1.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.6 | 3.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 2.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 0.6 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.6 | 0.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 1.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.6 | 1.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.6 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.6 | 5.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.6 | 3.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.6 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 1.9 | GO:0009624 | response to nematode(GO:0009624) |
0.6 | 1.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 5.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.6 | 9.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 0.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 2.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 2.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 5.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 1.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 9.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.6 | 4.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 5.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 1.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 2.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 1.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.6 | 1.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.6 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 1.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 3.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.6 | 0.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.6 | 2.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.6 | 1.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 1.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 0.6 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.6 | 1.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.6 | 2.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 0.6 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.6 | 2.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.6 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 10.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.6 | 2.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 5.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.6 | 0.6 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.6 | 0.6 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 4.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.6 | 2.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 1.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.6 | 1.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.6 | 2.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 4.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.6 | 2.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 2.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 18.9 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 0.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.6 | 1.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.6 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 3.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 1.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 17.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.6 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 7.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 2.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 2.2 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.6 | 1.1 | GO:0033622 | integrin activation(GO:0033622) |
0.6 | 2.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.6 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.6 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.6 | 1.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 3.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.5 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 4.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 5.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.5 | 5.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 2.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.5 | 0.5 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 3.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 3.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 0.5 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.5 | 3.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 1.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 2.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 3.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 1.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 1.1 | GO:0015669 | gas transport(GO:0015669) |
0.5 | 1.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 20.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.5 | 3.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 2.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 1.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 1.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 4.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 0.5 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.5 | 1.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.5 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 4.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 1.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.5 | 0.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 2.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 0.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 1.0 | GO:0070268 | cornification(GO:0070268) |
0.5 | 2.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 13.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.5 | 1.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 3.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.5 | 1.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 10.8 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.5 | 1.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 4.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.5 | 1.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 | 9.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.5 | 0.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.5 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 2.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.5 | 2.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 1.0 | GO:0030421 | defecation(GO:0030421) |
0.5 | 9.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.5 | 0.5 | GO:1900408 | negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) |
0.5 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 2.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.5 | 1.0 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.5 | 3.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 2.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 10.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.5 | 1.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 1.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 1.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.5 | 1.9 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.5 | 2.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.5 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 1.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 1.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.5 | 3.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.5 | 1.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.5 | 1.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.5 | 1.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.5 | 1.9 | GO:0075733 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.5 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.9 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 3.8 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.5 | 1.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 0.5 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.5 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 3.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 0.5 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.5 | 26.1 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.5 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 0.9 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.5 | 1.4 | GO:1901563 | response to camptothecin(GO:1901563) |
0.5 | 0.5 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.5 | 4.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.5 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.5 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.5 | 10.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 1.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.5 | 0.5 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.5 | 1.4 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.5 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 7.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 9.5 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 1.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.5 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 5.4 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.4 | 2.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 2.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 3.1 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.4 | 0.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.4 | 5.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 3.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 2.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 1.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 3.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.4 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.4 | 0.4 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.4 | 2.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.4 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 3.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 0.4 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 5.0 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.4 | 0.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 3.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 0.4 | GO:0032196 | transposition(GO:0032196) |
0.4 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 2.5 | GO:0043102 | methionine metabolic process(GO:0006555) methionine biosynthetic process(GO:0009086) amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 0.4 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.4 | 1.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 2.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 3.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.4 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 2.8 | GO:0006560 | proline metabolic process(GO:0006560) |
0.4 | 6.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 1.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 2.8 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.4 | 1.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 7.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 0.4 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.4 | 2.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 0.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 10.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 2.3 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.4 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 2.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 3.5 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.4 | 1.6 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.4 | 1.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 4.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 5.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 0.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 1.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 4.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 0.4 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.4 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.4 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 3.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 1.1 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.4 | 7.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.4 | 15.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 0.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 3.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.4 | 2.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.4 | 1.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.4 | 7.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.4 | 6.9 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 0.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.4 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 5.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 9.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 5.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 2.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 0.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 2.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 2.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 0.7 | GO:0042148 | strand invasion(GO:0042148) |
0.3 | 2.1 | GO:0015893 | drug transport(GO:0015893) |
0.3 | 3.4 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.3 | 1.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 1.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 35.7 | GO:0045087 | innate immune response(GO:0045087) |
0.3 | 1.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.3 | 2.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 1.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 4.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 0.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 2.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.3 | 6.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 8.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 3.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.3 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.6 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.3 | 2.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 2.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 6.4 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 3.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 12.8 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.3 | 0.9 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.3 | 1.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 4.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 12.9 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.3 | 3.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.3 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.3 | 1.5 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 1.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 1.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.3 | 2.1 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.3 | 19.9 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.3 | 0.6 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 2.9 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 3.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.3 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 3.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 4.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.4 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 0.6 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.3 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 0.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.1 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.3 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.3 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 4.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.9 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.3 | 1.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 0.5 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.3 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 2.9 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.8 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 0.5 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 1.6 | GO:0034397 | telomere localization(GO:0034397) |
0.3 | 0.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 6.2 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.3 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.3 | 4.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 3.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 1.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.2 | 1.2 | GO:0035561 | regulation of chromatin binding(GO:0035561) positive regulation of chromatin binding(GO:0035563) |
0.2 | 6.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 7.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 8.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 2.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.5 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.2 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 1.6 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.2 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 1.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.2 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 1.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 1.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.8 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.2 | 2.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 1.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 2.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 1.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 7.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 3.8 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 2.5 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 6.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 2.4 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.2 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.4 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 2.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 2.5 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.2 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.7 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.2 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.5 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.2 | 1.2 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 3.8 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 2.2 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.2 | 0.3 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.2 | 1.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 6.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 2.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 1.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.6 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.2 | 0.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 13.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.2 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.2 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.8 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 4.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.1 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.1 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 4.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 1.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 0.8 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0046033 | AMP biosynthetic process(GO:0006167) AMP metabolic process(GO:0046033) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 5.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 3.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.0 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.3 | GO:0043038 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 7.9 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.2 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 4.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.1 | 0.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.1 | 0.8 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 1.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.0 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.0 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0044321 | response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 2.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0072376 | protein activation cascade(GO:0072376) |
0.0 | 0.0 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 25.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
6.2 | 30.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.7 | 28.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.6 | 27.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.4 | 8.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.8 | 22.7 | GO:0031983 | vesicle lumen(GO:0031983) |
3.6 | 21.7 | GO:0097342 | ripoptosome(GO:0097342) |
3.6 | 17.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
3.5 | 52.2 | GO:0031430 | M band(GO:0031430) |
3.5 | 27.7 | GO:0030056 | hemidesmosome(GO:0030056) |
3.3 | 13.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.2 | 32.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
3.2 | 12.8 | GO:0030478 | actin cap(GO:0030478) |
3.2 | 12.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.1 | 24.7 | GO:0005861 | troponin complex(GO:0005861) |
2.9 | 20.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.9 | 17.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.8 | 17.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.7 | 13.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.6 | 13.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.5 | 15.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.4 | 2.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.4 | 33.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
2.4 | 14.2 | GO:0042629 | mast cell granule(GO:0042629) |
2.4 | 21.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.4 | 7.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
2.3 | 25.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.3 | 20.8 | GO:0005916 | fascia adherens(GO:0005916) |
2.3 | 9.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.2 | 9.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.2 | 10.9 | GO:0045180 | basal cortex(GO:0045180) |
2.2 | 28.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.2 | 6.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.1 | 10.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.1 | 6.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.1 | 4.2 | GO:0043292 | contractile fiber(GO:0043292) |
2.1 | 8.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.1 | 6.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.0 | 8.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.0 | 6.1 | GO:0005914 | spot adherens junction(GO:0005914) |
2.0 | 6.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.0 | 13.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.0 | 2.0 | GO:0016939 | kinesin II complex(GO:0016939) |
2.0 | 5.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.9 | 23.3 | GO:0031528 | microvillus membrane(GO:0031528) |
1.9 | 13.2 | GO:0016460 | myosin II complex(GO:0016460) |
1.9 | 1.9 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
1.9 | 37.1 | GO:0008305 | integrin complex(GO:0008305) |
1.8 | 3.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.8 | 3.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.7 | 3.5 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 123.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.7 | 8.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.7 | 43.7 | GO:0001772 | immunological synapse(GO:0001772) |
1.7 | 21.6 | GO:0002102 | podosome(GO:0002102) |
1.7 | 10.0 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.7 | 5.0 | GO:0005642 | annulate lamellae(GO:0005642) |
1.7 | 5.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.6 | 26.2 | GO:0031672 | A band(GO:0031672) |
1.6 | 4.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.6 | 11.4 | GO:0090543 | Flemming body(GO:0090543) |
1.6 | 67.3 | GO:0042641 | actomyosin(GO:0042641) |
1.6 | 20.3 | GO:0042581 | specific granule(GO:0042581) |
1.6 | 4.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.5 | 4.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.5 | 3.1 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 9.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.5 | 20.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
1.5 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
1.5 | 4.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.5 | 7.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 1.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.4 | 5.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 14.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 1.4 | GO:0032432 | actin filament bundle(GO:0032432) |
1.4 | 5.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.4 | 9.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.4 | 4.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.4 | 5.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.4 | 20.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.4 | 5.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 8.1 | GO:1990462 | omegasome(GO:1990462) |
1.3 | 6.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.3 | 2.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 5.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.3 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 5.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.3 | 1.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
1.3 | 6.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.3 | 7.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 13.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.2 | 5.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 3.7 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 7.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 2.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.2 | 7.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 3.6 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 10.8 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 6.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 4.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.2 | 5.9 | GO:0005579 | membrane attack complex(GO:0005579) |
1.2 | 11.7 | GO:0001527 | microfibril(GO:0001527) |
1.2 | 2.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.2 | 4.7 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 4.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.2 | 9.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.1 | 13.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.1 | 4.5 | GO:0042583 | chromaffin granule(GO:0042583) |
1.1 | 3.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 3.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.1 | 5.6 | GO:0097422 | tubular endosome(GO:0097422) |
1.1 | 3.4 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 10.0 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 3.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.1 | 3.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.1 | 13.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.1 | 26.4 | GO:0097228 | sperm principal piece(GO:0097228) |
1.1 | 20.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.1 | 7.6 | GO:0042588 | zymogen granule(GO:0042588) |
1.1 | 1.1 | GO:1990423 | RZZ complex(GO:1990423) |
1.1 | 4.3 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 10.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.0 | 3.1 | GO:0070552 | BRISC complex(GO:0070552) |
1.0 | 12.5 | GO:0043034 | costamere(GO:0043034) |
1.0 | 8.3 | GO:0031209 | SCAR complex(GO:0031209) |
1.0 | 2.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 4.1 | GO:0035339 | SPOTS complex(GO:0035339) |
1.0 | 6.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 2.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 62.6 | GO:0005581 | collagen trimer(GO:0005581) |
1.0 | 16.0 | GO:0000145 | exocyst(GO:0000145) |
1.0 | 38.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.0 | 29.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 7.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.0 | 2.0 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 2.9 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.0 | 237.7 | GO:0005925 | focal adhesion(GO:0005925) |
1.0 | 4.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 12.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 3.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.9 | 0.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.9 | 7.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 8.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 5.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.9 | 13.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 2.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.9 | 7.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.9 | 63.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 1.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 2.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.9 | 4.3 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 12.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 2.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 0.9 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 2.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 2.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 1.7 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 1.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.8 | 1.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 4.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.8 | 6.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 4.9 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 45.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 2.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.8 | 7.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 3.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 5.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.8 | 58.7 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 7.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 3.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 7.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.8 | 3.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.8 | 6.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 13.0 | GO:0030057 | desmosome(GO:0030057) |
0.8 | 2.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.8 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 3.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.7 | 3.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 2.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.7 | 4.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.7 | 3.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.7 | 27.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 2.2 | GO:0030689 | Noc complex(GO:0030689) |
0.7 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 1.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 5.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 6.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 4.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.7 | 4.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 4.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.7 | 4.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 6.1 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 8.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.7 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.7 | 31.3 | GO:0005902 | microvillus(GO:0005902) |
0.7 | 2.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 5.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.7 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 2.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.7 | 2.0 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.6 | 4.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 7.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.6 | 32.1 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 4.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.6 | 2.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 7.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 1.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 24.9 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 3.7 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 6.2 | GO:0005657 | replication fork(GO:0005657) |
0.6 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 9.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 6.0 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 6.6 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 29.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.6 | 2.4 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 15.7 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 6.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.7 | GO:0098687 | chromosomal region(GO:0098687) |
0.6 | 46.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 13.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 10.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.6 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 1.1 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 1.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 16.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.6 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 1.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 3.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 114.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 40.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 3.7 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 5.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 0.5 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.5 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 3.1 | GO:0032982 | myosin filament(GO:0032982) |
0.5 | 2.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 5.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.5 | 4.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 0.5 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.5 | 7.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 9.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 1.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 2.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 4.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 2.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 4.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 23.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 61.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 4.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 4.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 24.5 | GO:0005604 | basement membrane(GO:0005604) |
0.5 | 2.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 1.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 5.6 | GO:0038201 | TOR complex(GO:0038201) |
0.5 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 1.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 19.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.5 | 29.2 | GO:0030016 | myofibril(GO:0030016) |
0.5 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 3.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 3.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.5 | 1.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.4 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 3.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 3.6 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 28.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 0.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.4 | 1.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.4 | 33.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 11.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 125.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.4 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 2.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 3.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 2.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 18.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.4 | 18.6 | GO:0016605 | PML body(GO:0016605) |
0.4 | 6.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 17.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 1.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 7.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 14.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 1.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 1.8 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 1.8 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 89.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 546.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 19.3 | GO:0005819 | spindle(GO:0005819) |
0.3 | 24.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 3.2 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.3 | 2.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 2.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 2.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 13.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 4.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 10.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 0.3 | GO:0044449 | contractile fiber part(GO:0044449) |
0.3 | 1.5 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 21.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 2.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 2.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 3.1 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 3.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 3.3 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 2.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 25.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 3.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 5.3 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 3.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 10.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 1.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 6.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 4.9 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 2.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 105.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 27.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 13.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 2.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 2.1 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 89.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 6.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.9 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 12.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 5.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 2.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.7 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 28.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
7.0 | 35.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
6.5 | 19.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
5.7 | 22.8 | GO:0031433 | telethonin binding(GO:0031433) |
5.3 | 21.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
5.2 | 15.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
5.1 | 15.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
5.0 | 20.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.0 | 25.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
5.0 | 19.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
4.9 | 29.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
4.9 | 19.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
4.8 | 33.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.6 | 18.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
4.6 | 13.9 | GO:0051425 | PTB domain binding(GO:0051425) |
4.6 | 13.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
4.4 | 17.7 | GO:0015265 | urea channel activity(GO:0015265) |
4.3 | 12.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
4.2 | 12.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
4.1 | 16.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.0 | 12.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.9 | 11.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.9 | 11.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.8 | 23.0 | GO:0004064 | arylesterase activity(GO:0004064) |
3.7 | 22.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.7 | 26.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
3.6 | 10.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.6 | 7.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
3.5 | 42.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
3.5 | 3.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.4 | 10.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.4 | 10.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
3.4 | 20.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
3.3 | 20.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
3.3 | 9.8 | GO:0035877 | death effector domain binding(GO:0035877) |
3.3 | 39.0 | GO:0017166 | vinculin binding(GO:0017166) |
3.1 | 22.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.9 | 20.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.9 | 8.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.9 | 8.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.9 | 8.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.9 | 8.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.8 | 37.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
2.8 | 11.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.8 | 25.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.8 | 8.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.7 | 11.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.7 | 8.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.7 | 8.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
2.7 | 8.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.7 | 10.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.6 | 21.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.6 | 31.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.6 | 5.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
2.6 | 7.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.6 | 18.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.6 | 28.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.5 | 7.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.4 | 9.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.4 | 84.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
2.4 | 26.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.4 | 21.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.4 | 14.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.4 | 7.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
2.4 | 7.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.4 | 14.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.4 | 9.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.2 | 2.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.2 | 4.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.2 | 4.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.2 | 6.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.2 | 6.6 | GO:0008142 | oxysterol binding(GO:0008142) |
2.2 | 2.2 | GO:0043426 | MRF binding(GO:0043426) |
2.2 | 13.0 | GO:0016936 | galactoside binding(GO:0016936) |
2.2 | 8.7 | GO:0030984 | kininogen binding(GO:0030984) |
2.2 | 6.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.2 | 2.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.1 | 17.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.1 | 8.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.1 | 40.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.1 | 8.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.1 | 41.5 | GO:0030506 | ankyrin binding(GO:0030506) |
2.1 | 6.2 | GO:0031013 | troponin I binding(GO:0031013) |
2.1 | 6.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.1 | 45.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.0 | 14.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
2.0 | 8.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.0 | 2.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
2.0 | 8.0 | GO:0071253 | connexin binding(GO:0071253) |
2.0 | 4.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
2.0 | 7.9 | GO:0009374 | biotin binding(GO:0009374) |
2.0 | 5.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.0 | 7.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.0 | 7.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.9 | 5.8 | GO:0019862 | IgA binding(GO:0019862) |
1.9 | 19.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.9 | 19.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.9 | 9.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.9 | 5.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.9 | 9.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.9 | 3.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.9 | 5.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.9 | 5.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.9 | 5.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.9 | 1.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.9 | 3.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.8 | 9.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.8 | 14.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.8 | 5.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.8 | 7.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.8 | 5.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.8 | 5.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.8 | 21.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.8 | 1.8 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.8 | 9.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.8 | 9.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.8 | 1.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.8 | 3.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.8 | 1.8 | GO:0019213 | deacetylase activity(GO:0019213) |
1.7 | 5.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.7 | 6.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.7 | 61.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.7 | 5.2 | GO:0043199 | sulfate binding(GO:0043199) |
1.7 | 6.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.7 | 6.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.7 | 5.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.7 | 3.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.7 | 6.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.7 | 15.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.7 | 5.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.7 | 6.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.6 | 8.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.6 | 16.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.6 | 4.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.6 | 9.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 4.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 9.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.6 | 6.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.6 | 4.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.6 | 3.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.6 | 14.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.6 | 6.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.6 | 4.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.6 | 1.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.6 | 12.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.5 | 21.7 | GO:0008143 | poly(A) binding(GO:0008143) |
1.5 | 12.3 | GO:0044548 | S100 protein binding(GO:0044548) |
1.5 | 6.1 | GO:0043559 | insulin binding(GO:0043559) |
1.5 | 6.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.5 | 13.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.5 | 6.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.5 | 31.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.5 | 4.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.5 | 15.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.5 | 6.0 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.5 | 14.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.5 | 13.3 | GO:0005123 | death receptor binding(GO:0005123) |
1.5 | 4.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.5 | 26.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.4 | 4.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.4 | 15.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.4 | 12.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.4 | 10.0 | GO:0050700 | CARD domain binding(GO:0050700) |
1.4 | 2.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.4 | 2.8 | GO:0048030 | disaccharide binding(GO:0048030) |
1.4 | 15.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 24.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.4 | 5.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.4 | 4.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.4 | 18.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.4 | 11.1 | GO:0031432 | titin binding(GO:0031432) |
1.4 | 8.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 12.5 | GO:0030552 | cAMP binding(GO:0030552) |
1.4 | 5.5 | GO:0019808 | polyamine binding(GO:0019808) |
1.4 | 24.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.3 | 6.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.3 | 12.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.3 | 9.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.3 | 18.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.3 | 2.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.3 | 13.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.3 | 6.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.3 | 3.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.3 | 5.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.3 | 3.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.3 | 2.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.3 | 3.8 | GO:0015232 | heme transporter activity(GO:0015232) |
1.3 | 6.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 2.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 3.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.3 | 1.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.3 | 12.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.2 | 7.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.2 | 5.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.2 | 4.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.2 | 97.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.2 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 14.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.2 | 18.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.2 | 3.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.2 | 3.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.2 | 8.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.2 | 1.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.2 | 9.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.2 | 8.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
1.2 | 14.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 34.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.2 | 34.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 4.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 3.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 3.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.2 | 3.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.2 | 3.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.2 | 4.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.2 | 3.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.2 | 3.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.2 | 3.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.2 | 5.8 | GO:0035473 | lipase binding(GO:0035473) |
1.2 | 40.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.1 | 6.9 | GO:0039706 | co-receptor binding(GO:0039706) |
1.1 | 3.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.1 | 6.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.1 | 4.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.1 | 6.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.1 | 16.9 | GO:0004601 | peroxidase activity(GO:0004601) |
1.1 | 5.6 | GO:0017040 | ceramidase activity(GO:0017040) |
1.1 | 10.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.1 | 4.5 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.1 | 4.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.1 | 12.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.1 | 25.5 | GO:0043531 | ADP binding(GO:0043531) |
1.1 | 9.9 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.1 | 3.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.1 | 2.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
1.1 | 3.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.1 | 9.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.1 | 8.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.1 | 4.3 | GO:0016151 | nickel cation binding(GO:0016151) |
1.1 | 5.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 2.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.1 | 2.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.1 | 2.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.1 | 2.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.0 | 6.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.0 | 10.4 | GO:0030955 | potassium ion binding(GO:0030955) |
1.0 | 3.1 | GO:0051379 | epinephrine binding(GO:0051379) |
1.0 | 5.2 | GO:0008199 | ferric iron binding(GO:0008199) |
1.0 | 3.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 11.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.0 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.0 | 5.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.0 | 3.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.0 | 4.1 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 1.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.0 | 3.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.0 | 2.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.0 | 3.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 2.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.0 | 6.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 10.0 | GO:0035173 | histone kinase activity(GO:0035173) |
1.0 | 6.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.0 | 5.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.0 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.0 | 19.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.0 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.0 | 6.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 2.0 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
1.0 | 11.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.0 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.0 | 18.6 | GO:0045296 | cadherin binding(GO:0045296) |
1.0 | 4.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 7.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.0 | 5.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.0 | 3.9 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 1.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.0 | 7.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 3.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.0 | 1.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.0 | 1.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.9 | 0.9 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.9 | 2.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 2.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.9 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 3.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 4.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.9 | 3.7 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.9 | 2.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.9 | 17.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.9 | 5.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 9.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.9 | 1.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.9 | 5.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.9 | 47.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.9 | 3.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.9 | 6.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.9 | 3.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.9 | 1.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.9 | 2.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 4.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.9 | 2.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.9 | 6.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.9 | 4.4 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 3.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 6.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 3.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 2.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.9 | 4.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.9 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.9 | 6.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.9 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.9 | 17.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 2.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 5.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.8 | 3.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.8 | 3.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 5.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 4.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 5.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.8 | 2.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 3.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 1.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.8 | 23.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.8 | 6.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.8 | 2.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 3.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 2.5 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.8 | 4.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 3.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.8 | 14.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.8 | 6.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.8 | 5.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 14.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.8 | 3.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 14.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 4.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.8 | 14.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 2.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 14.3 | GO:0001848 | complement binding(GO:0001848) |
0.8 | 2.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.8 | 11.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.8 | 2.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 2.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.8 | 3.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.8 | 3.9 | GO:0005536 | glucose binding(GO:0005536) |
0.8 | 2.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.8 | 13.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.8 | 7.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 2.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 3.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.8 | 0.8 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.8 | 54.9 | GO:0005178 | integrin binding(GO:0005178) |
0.8 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 2.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 3.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.8 | 2.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 1.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.7 | 5.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 2.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 9.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.7 | 82.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 5.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.7 | 2.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 0.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.7 | 12.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.7 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 24.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.7 | 8.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.7 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 6.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 11.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.7 | 2.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 3.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.7 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 2.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 6.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.7 | 4.8 | GO:0070513 | death domain binding(GO:0070513) |
0.7 | 8.2 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.7 | 9.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 5.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 12.2 | GO:0005537 | mannose binding(GO:0005537) |
0.7 | 2.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 7.4 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 6.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 4.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 4.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 2.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 7.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 2.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 2.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.7 | 2.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.7 | 18.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 2.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.7 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 4.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 2.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.7 | 2.0 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.7 | 3.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.7 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.6 | 3.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 3.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 4.5 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 5.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 5.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.6 | 13.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.6 | 2.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 2.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 12.0 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.6 | 1.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.6 | 4.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.6 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 2.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.6 | 16.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.6 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.6 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 4.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 7.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 2.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 1.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 10.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 4.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 3.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.6 | 2.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.6 | 1.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 9.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 26.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.6 | 3.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 2.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 1.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 15.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 0.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.6 | 1.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.6 | 3.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 2.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 24.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 2.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.6 | 7.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.5 | 6.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 6.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 3.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 4.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 17.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.5 | 7.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 2.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 2.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 16.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 1.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.5 | 13.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 1.6 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 6.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 2.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 6.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.5 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 31.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 1.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 10.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 15.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 1.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 3.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 17.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 2.0 | GO:0019864 | IgG binding(GO:0019864) |
0.5 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 26.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.5 | 6.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 5.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 2.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 0.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 8.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.5 | 15.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.5 | 6.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 4.3 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.5 | 3.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 1.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 0.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.5 | 12.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.5 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 5.2 | GO:0071949 | FAD binding(GO:0071949) |
0.5 | 6.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 0.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 2.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 43.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.5 | 14.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.5 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.5 | 1.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 1.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 0.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 6.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 69.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 17.3 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 4.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 4.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 1.8 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 4.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 3.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 4.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 3.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.4 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 18.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 0.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 1.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 2.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 12.0 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.4 | 7.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 18.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.4 | 2.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 12.2 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.4 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 5.2 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 10.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 3.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 70.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 1.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 2.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 0.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 2.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 7.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 1.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 0.4 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.4 | 1.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 2.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 2.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 0.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 8.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 27.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 8.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 2.0 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 6.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 2.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 3.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 2.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 12.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.3 | 0.3 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 4.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 9.6 | GO:0060090 | binding, bridging(GO:0060090) |
0.3 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 2.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 2.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 2.4 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.3 | 0.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.9 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 21.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 5.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 2.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.3 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 5.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 55.2 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 11.3 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 2.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 2.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 3.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 7.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 9.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 10.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 5.2 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 2.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 3.1 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 6.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 3.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 4.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 3.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 5.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 7.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 4.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 4.8 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 5.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 29.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.5 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.2 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 3.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 2.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 2.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 21.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 11.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.7 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 4.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 3.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 6.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 3.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 7.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 8.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 1.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 8.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 1.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 27.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 1.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 7.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.2 | 114.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.9 | 125.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.7 | 35.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.5 | 68.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.5 | 52.3 | PID EPO PATHWAY | EPO signaling pathway |
2.5 | 103.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.3 | 6.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.3 | 95.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.3 | 58.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.2 | 15.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.2 | 8.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
2.2 | 17.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.2 | 13.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.1 | 2.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
2.1 | 12.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.1 | 38.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
2.0 | 22.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.9 | 5.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.8 | 5.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.8 | 9.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.8 | 47.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.8 | 93.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.8 | 18.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.8 | 66.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.8 | 50.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.8 | 42.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.8 | 12.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.7 | 71.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.6 | 6.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.6 | 51.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.6 | 8.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.6 | 24.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.5 | 12.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.5 | 10.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.5 | 68.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.5 | 12.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.5 | 6.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.5 | 28.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.5 | 6.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.5 | 31.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.5 | 17.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.5 | 20.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.4 | 8.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 21.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.4 | 38.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.4 | 16.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.4 | 4.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.4 | 1.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.3 | 36.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.3 | 4.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 15.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.3 | 16.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.3 | 20.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.3 | 15.3 | PID ALK1 PATHWAY | ALK1 signaling events |
1.3 | 6.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.3 | 12.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 36.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.2 | 14.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.2 | 14.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 4.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.2 | 34.8 | PID PLK1 PATHWAY | PLK1 signaling events |
1.2 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.1 | 6.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 17.8 | PID RAS PATHWAY | Regulation of Ras family activation |
1.1 | 7.5 | PID ENDOTHELIN PATHWAY | Endothelins |
1.1 | 9.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.1 | 5.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 2.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.0 | 34.1 | PID E2F PATHWAY | E2F transcription factor network |
1.0 | 39.0 | PID P73PATHWAY | p73 transcription factor network |
1.0 | 10.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.0 | 3.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.0 | 2.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 7.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.9 | 4.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.9 | 60.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.9 | 14.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 17.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.9 | 9.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.9 | 33.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.9 | 5.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 18.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.9 | 11.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 16.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 5.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 3.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 13.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.8 | 9.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 3.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 5.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 4.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 31.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 17.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 7.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 7.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 6.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 4.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 4.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 1.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 7.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 12.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 106.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 5.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 4.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 3.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 7.7 | PID ATM PATHWAY | ATM pathway |
0.5 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 6.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 9.2 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 11.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 5.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 5.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 8.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 1.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 2.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 1.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 3.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 4.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 2.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 2.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 5.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 35.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 3.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 3.2 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 6.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 43.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.1 | 57.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.2 | 74.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.0 | 3.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
3.0 | 3.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.9 | 20.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.8 | 31.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.8 | 34.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.8 | 69.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.7 | 27.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.7 | 27.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.7 | 62.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.6 | 31.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.6 | 23.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.5 | 20.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.5 | 92.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.5 | 19.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.4 | 2.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.3 | 13.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.2 | 47.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.0 | 36.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.0 | 20.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.0 | 29.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.0 | 55.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.0 | 21.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.9 | 21.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.9 | 19.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.9 | 56.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.8 | 1.8 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
1.8 | 17.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.7 | 17.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.7 | 13.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.7 | 25.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 27.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.7 | 58.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.7 | 159.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.7 | 18.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.6 | 4.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.6 | 22.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.6 | 20.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
1.6 | 7.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.6 | 37.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.5 | 33.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.5 | 1.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
1.5 | 16.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.5 | 35.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.4 | 8.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 14.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.4 | 33.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.4 | 17.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.4 | 8.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.4 | 5.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.4 | 136.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.4 | 31.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.4 | 4.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.3 | 17.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.3 | 14.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.3 | 13.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.3 | 11.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.3 | 35.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.3 | 12.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.3 | 10.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.2 | 4.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.2 | 4.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 1.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.2 | 2.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.2 | 3.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.2 | 56.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.2 | 8.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.2 | 32.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.2 | 10.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.2 | 8.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 4.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.1 | 7.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.1 | 4.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.1 | 7.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.1 | 4.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.1 | 12.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 31.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.1 | 14.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.0 | 15.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.0 | 23.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 11.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.0 | 12.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.0 | 3.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
1.0 | 8.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
1.0 | 14.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.0 | 1.0 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
1.0 | 4.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 42.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.9 | 4.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 0.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.9 | 4.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.9 | 9.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.9 | 4.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 8.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 32.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 5.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.9 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.9 | 17.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.9 | 8.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.9 | 18.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 5.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 4.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.8 | 47.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 11.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.8 | 8.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.8 | 16.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.8 | 13.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.8 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 10.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.8 | 8.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.8 | 3.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 6.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 0.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.8 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.8 | 6.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 6.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 5.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 7.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 7.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 13.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.7 | 6.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 13.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.7 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 10.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.7 | 7.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.7 | 46.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 7.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 12.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.6 | 9.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.6 | 3.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.6 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.6 | 5.0 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 29.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 9.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 5.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 5.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 2.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 18.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 7.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 1.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 4.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 2.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 6.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 3.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 10.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 2.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 1.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 11.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 3.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 0.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 5.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 2.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 10.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 6.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 4.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 4.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 2.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 7.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 1.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 3.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.4 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 1.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 10.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 1.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.4 | 3.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 10.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 26.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 33.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 4.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 5.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 0.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 4.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 5.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 5.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 3.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 3.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 0.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 3.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 5.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 3.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 1.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 1.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 11.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 1.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 4.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 16.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 4.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 5.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 4.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 22.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 8.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 4.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.2 | 4.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 10.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.9 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 1.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |